---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-001328"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-03-06T23:59:59+00:00"
generated_at: "2026-06-18T11:25:06.936053+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health issues €4.1M secured note to Cana Holdings; acquisition planned by March 31, 2023

## Summary
- Cosmos Health issued a €4.1M secured promissory note to Cana Holdings, bearing interest at 5% + 1-month LIBOR, maturing in 5 years.
- Note is secured by share pledges over all shares of Cana Holdings and its subsidiary Cana Pharmaceutical.
- This is the first step of a two-step transaction; the second step is acquisition of all Cana Holdings shares by Cosmos Health by March 31, 2023.
- Proceeds may not be used for capitalization or debt repayment without Cosmos Health's consent.
- Cross-default provision: a default under any other financial instrument causing Material Adverse Effect can trigger default under this note.

## SEC filing metadata
- accession: 0001477932-23-001328
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-03-06T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223001328/0001477932-23-001328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223001328/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-001328
- JSON: https://secwatch.observer/filing/0001477932-23-001328.json
- Plain text: https://secwatch.observer/filing/0001477932-23-001328.txt

## Key facts
- Material Agreements
  Cosmos Health Inc. entered into Secured Promissory Note with Cana Laboratories Holdings (Cyprus) Limited valued at 5,000,000 EUR (effective 2023-02-28).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Cana Laboratories Holdings (Cyprus) Limited
  - Value: 5,000,000 EUR
  - Effective: 2023-02-28
  source text: On February 28, 2023, Cosmos Health Inc. (the “Company”) was issued a five-year secured promissory note (the “Note”) in the principal amount of 4,100,000.00 EUR by Cana Laboratories Holdings (Cyprus) Limited, a corporation organized under the laws of the Republic of Cyprus (“Cana Holdings”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223001328/0001477932-23-001328-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.